The Pharmaceutical Care to Renal Transplant Recipient with Infectious Complications from the Viewpoint of Drug Interaction
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: ZHU, Man (Chinese PLA General Hospital, Dept of Pharmaceutical care, Beijing, China)
Some of antimicrobial agents have been shown to produce significant drug-drug interactions through the inhibition of cytochrome P450 enzymes. In renal transplant patients, these interactions pose potentially serious problems for the antimicrobial efficacy and the safe administration of cyclosporine A(CsA) or tacrolimus, a substrate of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.